García-Lorda P, Bulló M, Vilà R, del Mar Grasa M, Alemany M, Salas-Salvadó J
Unitat de Nutrició Humana, Hospital Universitari Sant Joan de Reus, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Spain.
Diabetes Nutr Metab. 2001 Dec;14(6):329-36.
To investigate the determinants of leptinemia in a cohort of morbid obese females compared to those of normal weight and mild-to-moderate obesity, and the relationships between leptin and metabolic derangements associated with obesity.
Recruited females were: moderately obese [n=44; body mass index (BMI) 25-40 kg/m2], morbidly obese (n=34; BMI > or = 40 kg/m2) and normal weight volunteers (n=12; BMI 19-25 kg/m2). Fat mass assessed by bioelectrical impedance and fat distribution by waist-to-hip ratio (WHR) were determined in all subjects. Biochemical determinations included plasma leptin, lipoprotein profile, fasting insulin and cortisol.
Plasma leptin values were significantly increased in morbid obese patients (54.95 +/- 1.8 ng/ml) compared to those moderately obese (30.2 +/- 1.7 ng/ml; p<0.001) and to controls (9.77 +/- 1.4 ng/ml; p<0.001). Fat and age-adjusted leptin values were not different between groups. When subjects with a BMI <40 kg/m2 were considered, plasma leptin was significantly and positively related to anthropometric variables (BMI, percentage body fat and WHR), total cholesterol, LDL-cholesterol, plasma triglycerides, AST, ALT and uric acid; and negatively with HDL-cholesterol. In contrast, when morbidly obese patients were analyzed separately, no relationships were observed between leptin concentrations and BMI, percentage of adiposity or biochemical variables. For obese patients no significant differences were observed in the adjusted leptin values with respect to the presence of diabetes, dyslipidemia or hypertension.
In morbidly obese women, the plasma leptin concentrations, although increased, do not reflect the amount of adipose stores, and as such, factors other than simply adiposity need to be invoked to explain the variation in leptin values.
研究病态肥胖女性队列中瘦素血症的决定因素,并与正常体重及轻至中度肥胖女性进行比较,同时研究瘦素与肥胖相关代谢紊乱之间的关系。
招募的女性包括:中度肥胖者[44例;体重指数(BMI)25 - 40kg/m²]、病态肥胖者(34例;BMI≥40kg/m²)和正常体重志愿者(12例;BMI 19 - 25kg/m²)。所有受试者均通过生物电阻抗法测定脂肪量,通过腰臀比(WHR)测定脂肪分布。生化检测包括血浆瘦素、脂蛋白谱、空腹胰岛素和皮质醇。
与中度肥胖者(30.2±1.7ng/ml;p<0.001)和对照组(9.77±1.4ng/ml;p<0.001)相比,病态肥胖患者的血浆瘦素值显著升高(54.95±1.8ng/ml)。调整脂肪和年龄后的瘦素值在各组之间无差异。当考虑BMI<40kg/m²的受试者时,血浆瘦素与人体测量学变量(BMI、体脂百分比和WHR)、总胆固醇、低密度脂蛋白胆固醇、血浆甘油三酯、谷草转氨酶、谷丙转氨酶和尿酸显著正相关;与高密度脂蛋白胆固醇呈负相关。相反,当单独分析病态肥胖患者时,未观察到瘦素浓度与BMI、肥胖百分比或生化变量之间的关系。对于肥胖患者,在调整后的瘦素值方面,糖尿病、血脂异常或高血压的存在与否无显著差异。
在病态肥胖女性中,血浆瘦素浓度虽升高,但并不反映脂肪储存量,因此,需要引入除单纯肥胖之外的其他因素来解释瘦素值的变化。